You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR METOCLOPRAMIDE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for METOCLOPRAMIDE HYDROCHLORIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003213 ↗	Drugs to Reduce the Side Effects of Chemotherapy	Completed	Swiss Group for Clinical Cancer Research	Phase 3	1996-05-01	RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients treated with chemotherapy. It is not known whether receiving dexamethasone with granisetron is more effective than receiving dexamethasone with metoclopramide for reducing the side effects of chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of dexamethasone with either granisetron or metoclopramide in patients treated with chemotherapy.
NCT00008736 ↗	Electrogastrography (EGC) in Premature Infants With Feeding Intolerance	Completed	Children's Hospital of Philadelphia	Phase 2	1969-12-31	Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
NCT00008736 ↗	Electrogastrography (EGC) in Premature Infants With Feeding Intolerance	Completed	National Center for Research Resources (NCRR)	Phase 2	1969-12-31	Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for METOCLOPRAMIDE HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for METOCLOPRAMIDE HYDROCHLORIDE
Intervention	Trials
Nausea	17
Migraine	14
Postoperative Nausea and Vomiting	14
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for METOCLOPRAMIDE HYDROCHLORIDE
Intervention	Trials
Vomiting	51
Nausea	43
Migraine Disorders	32
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for METOCLOPRAMIDE HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for METOCLOPRAMIDE HYDROCHLORIDE
Location	Trials
United States	219
Egypt	36
Canada	20
Australia	16
Turkey	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for METOCLOPRAMIDE HYDROCHLORIDE
Location	Trials
New York	28
Pennsylvania	15
Texas	13
Illinois	11
Ohio	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for METOCLOPRAMIDE HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for METOCLOPRAMIDE HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	94
Phase 3	36
Phase 2/Phase 3	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for METOCLOPRAMIDE HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	139
Recruiting	36
Not yet recruiting	31
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for METOCLOPRAMIDE HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for METOCLOPRAMIDE HYDROCHLORIDE
Sponsor	Trials
Montefiore Medical Center	13
Assiut University	11
Cairo University	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for METOCLOPRAMIDE HYDROCHLORIDE
Sponsor	Trials
Other	316
Industry	36
NIH	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.